Compare Cronos Group Inc (CRON) vs iShares 3 7 Year Treasury Bond ETF (IEI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs iShares 3 7 Year Treasury Bond ETF — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.18B), while iShares 3 7 Year Treasury Bond ETF trades at $113.45 (market cap $16.72B). The key difference: iShares 3 7 Year Treasury Bond ETF is far larger — about 14.2× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, iShares 3 7 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and iShares 3 7 Year Treasury Bond ETF for 43 Days on average.
| CRON | IEI | |
|---|---|---|
Market Cap | $1.18B | $16.72B |
Volume | 968,037 | 3,963,319 |
Sector | Health | Fixed Income |
52-Week High | $3.55 | $120.72 |
52-Week Low | $2.30 | $113.17 |
Typical Hold Time | 22 Days | 43 Days |
Enterprise Value | $387.62M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.
Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.
IEI trades at $113.41, showing minimal daily movement with a 0.03% gain. Technical indicators signal a bearish trend with moving averages and ADX pointing downward, though oscillators remain neutral. Recent dividend payments of $0.37-0.38 per share provide income stability. The stock faces headwinds from broader bond market volatility as Treasury yields reach multi-decade highs, impacting fixed-income related equities.
The outlook remains cautious amid persistent bond market pressures. While dividend payments offer some support, the bearish technical setup and elevated Treasury yields create near-term challenges. Investment opportunity exists for income-focused investors, but requires careful monitoring of interest rate developments and bond market stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About iShares 3 7 Year Treasury Bond ETF
IEI tracks the ICE U.S. Treasury 3-7 Year Bond Index, offering exposure to intermediate-term government debt. It serves as a conservative middle ground in the Treasury yield curve, providing higher yields than short-term bills with less volatility than long-term bonds.
Read more on IEI →
